Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of PROC mRNA | affects expression | 21346803
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of PROC protein | affects expression | 20106945
|
D000638 |
Amiodarone |
Amiodarone affects the expression of PROC mRNA | affects expression | 19483382
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of PROC mRNA | affects expression | 16483693
|
D001553 |
Benzbromarone |
Benzbromarone affects the expression of PROC mRNA | affects expression | 19483382
|
D001554 |
Benzene |
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of PROC mRNA | affects cotreatment|decreases expression | 17905399
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of PROC mRNA | decreases expression | 20106945
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of PROC mRNA | increases expression | 20504355
|
D002994 |
Clofibrate |
Clofibrate affects the expression of PROC mRNA | affects expression | 19483382
|
D003276 |
Contraceptives, Oral |
Contraceptives, Oral results in decreased expression of PROC | decreases expression | 15185533
|
C034528 |
CycloProvera |
CycloProvera results in decreased expression of PROC protein | decreases expression | 14561536
|
D016572 |
Cyclosporine |
Cyclosporine affects the expression of PROC mRNA | affects expression | 20106945
|
C023635 |
dienogest |
[Ethinyl Estradiol co-treated with dienogest] results in increased activity of PROC protein | affects cotreatment|increases activity | 15288212
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in decreased expression of PROC mRNA | decreases expression | 19638242
|
D004317 |
Doxorubicin |
Doxorubicin affects the metabolism of PROC protein | affects metabolic processing | 17172434
|
C418365 |
estradiol, norethindrone drug combination |
estradiol, norethindrone drug combination results in decreased expression of PROC protein | decreases expression | 14561536
|
C454300 |
estradiol valerate-dienogest |
[Ethinyl Estradiol co-treated with estradiol valerate-dienogest] results in increased activity of PROC protein | affects cotreatment|increases activity | 15288212
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol binds to Norethindrone] which results in increased expression of PROC protein | affects binding|increases expression | 14561536
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol co-treated with dienogest] results in increased activity of PROC protein | affects cotreatment|increases activity | 15288212
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol co-treated with estradiol valerate-dienogest] results in increased activity of PROC protein | affects cotreatment|increases activity | 15288212
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol co-treated with Gestodene] affects the expression of PROC protein | affects cotreatment|affects expression | 11720199
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol co-treated with Gestodene] results in increased activity of PROC protein | affects cotreatment|increases activity | 11994571
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol co-treated with Gestodene] results in increased expression of PROC | affects cotreatment|increases expression | 15669648
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol co-treated with Gestodene] results in increased expression of PROC protein | affects cotreatment|increases expression | 12618251
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol co-treated with Levonorgestrel] results in increased activity of PROC protein | affects cotreatment|increases activity | 15288212
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of PROC protein | affects cotreatment|increases expression | 14551147 12618251
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol co-treated with norgestimate] results in increased expression of PROC protein | affects cotreatment|increases expression | 12618251
|
C442659 |
ethinyl estradiol-desogestrel combination |
ethinyl estradiol-desogestrel combination results in decreased expression of PROC protein | decreases expression | 15318540
|
C442659 |
ethinyl estradiol-desogestrel combination |
ethinyl estradiol-desogestrel combination results in increased activity of PROC protein | increases activity | 11994571
|
C442659 |
ethinyl estradiol-desogestrel combination |
ethinyl estradiol-desogestrel combination results in increased expression of PROC protein | increases expression | 14551147 12618251 10928463
|
D005001 |
Ethionine |
Ethionine affects the expression of PROC mRNA | affects expression | 19483382
|
C033273 |
Gestodene |
[Ethinyl Estradiol co-treated with Gestodene] affects the expression of PROC protein | affects cotreatment|affects expression | 11720199
|
C033273 |
Gestodene |
[Ethinyl Estradiol co-treated with Gestodene] results in increased activity of PROC protein | affects cotreatment|increases activity | 11994571
|
C033273 |
Gestodene |
[Ethinyl Estradiol co-treated with Gestodene] results in increased expression of PROC | affects cotreatment|increases expression | 15669648
|
C033273 |
Gestodene |
[Ethinyl Estradiol co-treated with Gestodene] results in increased expression of PROC protein | affects cotreatment|increases expression | 12618251
|
C030957 |
methylmercury II |
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of PROC mRNA | affects cotreatment|decreases expression | 17905399
|
D009640 |
Norethindrone |
[Ethinyl Estradiol binds to Norethindrone] which results in increased expression of PROC protein | affects binding|increases expression | 14561536
|
C017576 |
norgestimate |
[Ethinyl Estradiol co-treated with norgestimate] results in increased expression of PROC protein | affects cotreatment|increases expression | 12618251
|
D016912 |
Levonorgestrel |
[Ethinyl Estradiol co-treated with Levonorgestrel] results in increased activity of PROC protein | affects cotreatment|increases activity | 15288212
|
D016912 |
Levonorgestrel |
[Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of PROC protein | affects cotreatment|increases expression | 14551147 12618251
|
D009853 |
Omeprazole |
Omeprazole affects the expression of PROC mRNA | affects expression | 19483382
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of PROC mRNA | decreases expression | 17950772
|
C006253 |
pirinixic acid |
PPARA protein promotes the reaction [pirinixic acid results in decreased expression of PROC mRNA] | decreases expression|increases reaction | 17950772
|
C006253 |
pirinixic acid |
pirinixic acid affects the expression of PROC mRNA | affects expression | 19483382
|
D011441 |
Propylthiouracil |
Propylthiouracil affects the expression of PROC mRNA | affects expression | 19483382
|
D020849 |
Raloxifene |
Raloxifene results in decreased activity of PROC protein | decreases activity | 16359964
|
D013629 |
Tamoxifen |
Tamoxifen results in decreased expression of PROC protein | decreases expression | 15850603
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of PROC mRNA | increases expression | 15644576
|
D013853 |
Thioacetamide |
Thioacetamide affects the expression of PROC mRNA | affects expression | 19483382
|
D014241 |
Trichloroethylene |
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of PROC mRNA | affects cotreatment|decreases expression | 17905399
|
D014859 |
Warfarin |
PROC gene polymorphism affects the susceptibility to Warfarin | affects response to substance | 17048007
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.22 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.53 | 11752688 14514962 15322242 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.23 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
11.21 | 17505938 |
MESH:D000152 |
Acne Vulgaris |
|
norgestimate |
11.21 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.82 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
6.54 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
6.54 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
6.54 | 14692618 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
6.00 | 6695378 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
6.00 | 6695378 10737359 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
15.39 | 17620307 16434500 19061943 17162532 18056438 19052882 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
15.39 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
15.39 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
10.43 | 21441931 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
10.43 | 17308373 17451421 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
2.47 | 15800139 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.67 | 11748828 |
MESH:D000741 |
Anemia, Aplastic |
|
Benzene |
4.12 | 17661222 14761424 11369114 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.76 | 19183758 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Amiodarone |
3.52 | 18218290 20041841 18057881 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.15 | 11256880 |
MESH:D001167 |
Arteritis |
marker/mechanism |
|
| 17139375 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.46 | 15885639 |
MESH:D001281 |
Atrial Fibrillation |
|
Amiodarone |
3.66 | 19698954 18651412 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Amiodarone |
52.54 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Benzbromarone |
52.54 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Clofibrate |
52.54 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Ethionine |
52.54 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Omeprazole |
52.54 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
52.54 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Propylthiouracil |
52.54 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
52.54 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Thioacetamide |
52.54 | 19483382 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.46 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.56 | 15746008 |
MESH:D001855 |
Bone Marrow Diseases |
|
Benzene |
4.90 | 16183116 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.37 | 14601052 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.16 | 16580743 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.53 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Benzene |
4.44 | 11921183 17162533 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
4.44 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
4.44 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
4.44 | 15993339 17369602 18628466 16322301 15994142 19526202 16096432 18382427 15634643 15668708 16595493 16115903 15136595 17426702 18695136 15567936 15939500 11325840 16826403 16935488 15692762 18234424 16264153 17983394 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
4.44 | 17242785 15775269 16912660 17440819 15758505 17049068 15572757 17261762 17893378 17952589 16837676 17595753 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
4.44 | 19084267 18997820 17893378 16202921 19221464 18629630 11161223 18984771 20544844 19066611 17049068 17261762 19011961 20065188 18815881 19244106 20135344 20390343 17440819 18425577 18855134 19289846 19487384 20859285 19115204 18821012 19189212 19288272 21138602 21152245 19410462 19059307 18351453 19200415 15565566 20005174 19189210 19103187 15668708 16818667 19155303 17242785 16873071 19142967 16273361 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
4.44 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Trichloroethylene |
4.44 | 15986119 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.48 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.55 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.19 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
13.18 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
13.18 | 12907637 12619106 21507988 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Benzbromarone |
13.18 | 1701930 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
13.18 | 18393292 17162532 20084675 18788625 18506893 16698587 17173139 16779866 19171122 20432363 20214788 10672840 20524982 19107877 19208518 21159647 16569478 16540662 20727157 17055752 16807293 19919837 19519916 18971187 16288022 19418558 17978847 20007298 19701751 16830150 18210153 18056438 3084413 10737359 17761372 20935162 19539802 18691550 17138121 20512989 16502159 17428255 16328049 18494052 18785209 3581430 19052882 19335982 11831363 18665156 16935385 16681979 19394651 19383236 20514400 19822196 18978308 16878318 20101231 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
13.18 | 18059187 16234567 17876044 16023760 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
13.18 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Thioacetamide |
13.18 | 17997003 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
3.01 | 16201981 1485588 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
4.36 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
4.36 | 6189445 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
8.57 | 17572228 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
8.57 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.19 | 18850075 18670907 16120746 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.32 | 16455267 17131338 17329180 17382496 16952015 16731534 15792986 17974986 17007740 16109756 17928571 18627295 15811867 17924179 16612575 16651473 16242529 15505089 15476868 16269455 16278810 16364871 17308081 17519947 17351982 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Amiodarone |
5.59 | 15710769 19225199 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
5.59 | 16243910 17334414 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
3.22 | 15775269 |
MESH:D002341 |
Carotid Artery Thrombosis |
|
Amiodarone |
4.76 | 18974383 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
14.21 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Clofibrate |
14.21 | 1399818 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
14.21 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
14.21 | 17174075 21159647 2727394 7505956 |
MESH:D002543 |
Cerebral Hemorrhage |
|
Warfarin |
5.54 | 11061249 |
MESH:D002637 |
Chest Pain |
|
Omeprazole |
4.78 | 15447763 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
14.55 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
14.55 | 16835633 |
MESH:D018281 |
Cholangiocarcinoma |
|
Thioacetamide |
14.55 | 18291259 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
17.34 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
17.34 | 16105132 17110522 17681005 15861022 16919318 11677210 17333356 |
MESH:D002779 |
Cholestasis |
|
Levonorgestrel |
17.34 | 15861022 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
17.34 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
1.97 | 8697196 12621046 16354765 15668235 15340226 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.30 | 15800139 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.14 | 18259882 18802399 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.79 | 14669216 17141729 |
MESH:D023903 |
Coronary Restenosis |
|
Warfarin |
5.37 | 12872399 |
OMIM:122700 |
COUMARIN RESISTANCE |
|
Warfarin |
5.52 | 20579077 20497562 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Benzene |
2.57 | 15643154 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.57 | 15322242 10048152 20055451 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
3.70 | 18551238 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.04 | 19031437 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
3.89 | 17474826 |
MESH:D003872 |
Dermatitis |
|
Benzene |
4.45 | 15902427 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.27 | 18249437 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Warfarin |
3.95 | 18772604 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
3.93 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
3.93 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
13.68 | 17308373 15920148 17451421 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
13.68 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Warfarin |
13.68 | 12644472 |
MESH:D004211 |
Disseminated Intravascular Coagulation |
marker/mechanism |
|
| 18376272 |
MESH:D003875 |
Drug Eruptions |
|
Warfarin |
5.66 | 14723717 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
17.08 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Amiodarone |
17.08 | 18218290 15265979 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
17.08 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
17.08 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
17.08 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Thioacetamide |
17.08 | 12963478 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Trichloroethylene |
17.08 | 7120509 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
7.32 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
7.32 | 11462148 |
MESH:D004381 |
Duodenal Ulcer |
|
Omeprazole |
4.02 | 21218061 17151854 16613094 15991576 |
MESH:D050171 |
Dyslipidemias |
|
Clofibrate |
3.83 | 16707586 |
MESH:D004487 |
Edema |
|
pirinixic acid |
9.76 | 12083418 |
MESH:D004487 |
Edema |
|
Raloxifene |
9.76 | 15860553 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
9.76 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.57 | 18230668 15322242 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
13.56 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
13.56 | 15845917 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
13.56 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
6.86 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
6.86 | 20544844 19155303 16202921 17893378 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.74 | 9294722 10568697 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
4.83 | 18037988 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.79 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
1.93 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.77 | 11564622 |
MESH:D005218 |
Fat Necrosis |
|
Thioacetamide |
5.39 | 16456712 |
MESH:D005234 |
Fatty Liver |
|
Amiodarone |
38.26 | 14986274 |
MESH:D005234 |
Fatty Liver |
|
Clofibrate |
38.26 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
38.26 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
38.26 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
38.26 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
38.26 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
38.26 | 17473493 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
38.26 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.04 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.14 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.20 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
10.35 | 19069698 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
10.35 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
7.43 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
7.43 | 20067830 |
MESH:D006471 |
Gastrointestinal Hemorrhage |
|
Warfarin |
6.38 | 11794436 |
MESH:D005776 |
Gaucher Disease |
|
Warfarin |
5.65 | 12359135 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.89 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.14 | 17150277 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.26 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.31 | 15692506 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
5.87 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
5.87 | 10048152 11294989 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
7.09 | 16330681 16244372 17888722 18006777 12587719 14766674 16144979 16495754 16879835 17875725 16244371 16707910 18674790 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
7.09 | 11110106 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
6.38 | 17481944 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
6.38 | 20558911 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.61 | 15692506 |
MESH:D006402 |
Hematologic Diseases |
|
Benzene |
4.35 | 16183116 |
MESH:D006406 |
Hematoma |
|
Warfarin |
6.38 | 17493413 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.09 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
9.54 | 11000095 |
MESH:D006470 |
Hemorrhage |
|
Warfarin |
9.54 | 18429757 |
MESH:D006501 |
Hepatic Encephalopathy |
|
Thioacetamide |
4.28 | 18665440 15929193 17276928 |
MESH:D006505 |
Hepatitis |
|
Thioacetamide |
3.91 | 16456712 |
MESH:D006529 |
Hepatomegaly |
|
Amiodarone |
12.57 | 15265979 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
12.57 | 19772884 16221962 19176532 18467677 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
12.57 | 15340226 16120746 12621046 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.14 | 17606976 15147373 18501091 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.71 | 18606429 15340226 16354765 8697196 16959395 |
MESH:D006937 |
Hypercholesterolemia |
|
Amiodarone |
3.58 | 9751232 8137927 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.90 | 20558911 |
MESH:D006973 |
Hypertension |
|
Benzene |
11.32 | 17940673 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
11.32 | 10903974 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
11.32 | 15787275 17577099 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
11.32 | 18670907 18850075 |
MESH:D006976 |
Hypertension, Pulmonary |
|
Warfarin |
4.58 | 12359135 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.49 | 16945680 16569931 |
MESH:D007037 |
Hypothyroidism |
|
Amiodarone |
10.55 | 18020914 17991464 |
MESH:D007037 |
Hypothyroidism |
|
Propylthiouracil |
10.55 | 18031379 8137927 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.16 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.27 | 17937319 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
7.27 | 18785209 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
7.27 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
7.27 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.42 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.05 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.11 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
5.48 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
5.48 | 15699352 16775033 15369732 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
3.86 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
10.86 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
10.86 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
10.86 | 18625569 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.20 | 16973256 |
MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Omeprazole |
3.84 | 19248655 |
MESH:D007938 |
Leukemia |
|
Benzene |
3.23 | 17119257 18335105 15935818 14694614 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
4.83 | 16085563 |
MESH:D007951 |
Leukemia, Myeloid |
|
Benzene |
4.03 | 17506065 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Benzene |
2.64 | 19478238 |
MESH:D008064 |
Lipidoses |
|
Amiodarone |
7.15 | 17567588 15342952 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
7.15 | 15342952 17567588 |
MESH:D054068 |
Livedo Reticularis |
|
Warfarin |
6.38 | 18280355 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.65 | 20032147 18665156 18522880 19638242 18407596 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
6.26 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
6.26 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
6.26 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
6.26 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Thioacetamide |
6.26 | 12175628 15316131 12557150 18032466 15716488 18380797 12531686 15078482 10677585 12679928 18458672 15474484 16511523 17292413 16097051 17127702 15334695 15288472 12085344 17355460 18615449 14739098 16489207 18295389 15465738 16343077 16098781 11172339 12891558 15095483 11481614 18263696 15362042 11682029 18395095 17629604 16248980 16126171 18606216 18416461 18031379 15288473 15158331 15075984 17050028 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
4.00 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
Thioacetamide |
4.00 | 18374380 16337175 15158337 |
MESH:D017114 |
Liver Failure, Acute |
|
Thioacetamide |
4.03 | 12479984 15633222 15313186 17276928 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
19.91 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
19.91 | 18177683 15890375 9163691 2125692 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
19.91 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
19.91 | 15175105 15885732 20137499 19073162 20452335 20434301 20492335 20583210 19426721 19996281 18648771 19255062 21278145 19256749 20101389 19850985 10737359 16942905 18644402 18978307 19294768 20118626 19812893 2422723 19638242 19833225 12771043 9163691 20405173 21047994 19254457 19090486 19690152 20501860 19499222 19551842 18754104 21071580 12112319 21167192 18977376 19642983 2862719 19427195 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
19.91 | 20007298 15890375 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
19.91 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
19.91 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
25.15 | 6135515 2876784 2876786 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
25.15 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Benzene |
25.15 | 12562636 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
25.15 | 18079962 19519916 18775883 18093689 18253720 17174075 18544905 19539802 18164116 18282651 17942915 2563599 19004024 17854601 3124819 21159647 16267830 18308698 19009564 9362446 16842330 19126423 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
25.15 | 16842330 17085340 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
25.15 | 12151625 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Trichloroethylene |
25.15 | 7955063 |
MESH:D008133 |
Long QT Syndrome |
|
Amiodarone |
3.33 | 17391786 15350150 11989578 |
MESH:D008171 |
Lung Diseases |
|
Amiodarone |
3.16 | 12587719 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Amiodarone |
10.36 | 18516814 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Benzene |
10.36 | 14698565 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
10.00 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Benzene |
10.00 | 12562636 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
10.00 | 18816296 20064080 20464547 17053015 20135361 18520028 6695378 20869020 18569708 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
10.00 | 21163286 6695378 20512841 20970405 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
10.00 | 6189445 17418594 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
10.00 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
10.00 | 19555203 11884234 |
MESH:D008223 |
Lymphoma |
|
Benzene |
7.08 | 17119257 17584886 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
7.08 | 16098063 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.53 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.25 | 15621674 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Benzene |
8.99 | 12562636 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
8.99 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Benzene |
8.88 | 11921183 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
8.88 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
8.88 | 16827153 11731420 19196722 14580682 19196723 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.22 | 19453300 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
3.21 | 16827129 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
3.21 | 19393235 12393984 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.86 | 15990972 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
2.93 | 17638057 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.46 | 16801185 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.21 | 15792986 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.22 | 15863610 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
2.94 | 16381670 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.46 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
Benzene |
6.85 | 17119195 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
6.85 | 16497877 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.19 | 16239165 |
MESH:D009181 |
Mycoses |
|
Amiodarone |
4.57 | 17974566 12754197 |
MESH:D009203 |
Myocardial Infarction |
|
Contraceptives, Oral |
8.98 | 11752354 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
8.98 | 15857846 19429709 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
8.98 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.76 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.70 | 16411023 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.22 | 16343187 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
9.88 | 18551238 7678174 |
MESH:D009336 |
Necrosis |
|
Warfarin |
9.88 | 14723717 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
8.74 | 9029167 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
8.74 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
8.74 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.41 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
7.39 | 11141357 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
7.39 | 17405874 |
MESH:D009369 |
Neoplasms |
|
Trichloroethylene |
7.39 | 11911487 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.67 | 19189210 19196722 19200415 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.45 | 16636307 16899518 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.11 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
8.39 | 18481113 19348381 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
8.39 | 16889571 15640375 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
2.91 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Benzene |
3.46 | 15643154 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.09 | 15555623 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.08 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.79 | 20387270 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
Clofibrate |
4.62 | 9802331 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.73 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
8.23 | 16049721 |
MESH:D009784 |
Occupational Diseases |
|
Benzene |
8.23 | 17119257 17178637 15612468 17479406 15913788 16737584 15727169 15576619 15935809 |
MESH:D010024 |
Osteoporosis |
|
Levonorgestrel |
7.18 | 12665316 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
7.18 | 15775268 17882678 19059307 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
3.93 | 17823083 15579764 17893378 15758505 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.86 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
Benzene |
2.87 | 12562636 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
2.30 | 16540662 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.39 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.92 | 12520081 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
4.83 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
4.83 | 17638057 |
MESH:D011085 |
Polycystic Ovary Syndrome |
|
ethinyl estradiol-desogestrel combination |
5.31 | 17105841 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.25 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
8.04 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
8.04 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
2.87 | 11222880 11896295 11118676 11399792 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.15 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
2.15 | 16888761 18437689 15749863 16868541 15897917 16729912 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
2.15 | 15731164 16536755 16220300 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.15 | 15067354 |
MESH:D020151 |
Protein C Deficiency |
marker/mechanism|therapeutic |
|
| 18376272 14707701 |
MESH:D020151 |
Protein C Deficiency |
|
Warfarin |
6.02 | 18376272 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
8.92 | 15861022 16919318 |
MESH:D011537 |
Pruritus |
|
Levonorgestrel |
8.92 | 15861022 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.11 | 16882103 |
MESH:D011655 |
Pulmonary Embolism |
|
Warfarin |
6.02 | 19300499 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Amiodarone |
2.73 | 11597910 12490602 12832656 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.22 | 15770314 |
MESH:D055665 |
Purpura Fulminans |
marker/mechanism |
|
| 18376272 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
3.90 | 17922066 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.23 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.53 | 18990726 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.71 | 15625365 17710206 15675481 17203757 16767912 18313854 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
3.93 | 14601052 16326096 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.46 | 17846226 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.33 | 18551238 |
OMIM:609620 |
SHORT QT SYNDROME 1 |
|
Amiodarone |
4.76 | 18724381 |
MESH:D012851 |
Sinus Thrombosis, Intracranial |
|
Warfarin |
5.55 | 12269725 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
8.52 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
8.52 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
8.52 | 16192470 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.25 | 15625365 17203757 16767912 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
10.46 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
10.46 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.71 | 19457130 |
MESH:D013272 |
Stomach Diseases |
|
Omeprazole |
4.29 | 18545984 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzene |
3.22 | 12562636 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
3.22 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
3.22 | 18456281 |
MESH:D013276 |
Stomach Ulcer |
|
Amiodarone |
6.63 | 18087811 |
MESH:D013276 |
Stomach Ulcer |
|
Omeprazole |
6.63 | 16755016 18237397 11906479 15991576 10750652 17977527 |
MESH:D020521 |
Stroke |
|
Raloxifene |
8.40 | 16837676 |
MESH:D020521 |
Stroke |
|
Warfarin |
8.40 | 19300499 |
MESH:D013610 |
Tachycardia |
|
Amiodarone |
3.98 | 11238279 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Amiodarone |
3.88 | 19225199 |
MESH:D013923 |
Thromboembolism |
|
Warfarin |
5.83 | 18698879 16960144 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
23.63 | 11994571 |
MESH:D019851 |
Thrombophilia |
|
ethinyl estradiol-desogestrel combination |
23.63 | 11994571 |
MESH:D019851 |
Thrombophilia |
|
Gestodene |
23.63 | 11994571 |
MESH:D019851 |
Thrombophilia |
|
Warfarin |
23.63 | 17493413 |
OMIM:612304 |
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE |
marker/mechanism |
|
| |
MESH:D013927 |
Thrombosis |
marker/mechanism |
|
| 18376272 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
13.99 | 15669648 |
MESH:D013927 |
Thrombosis |
|
Gestodene |
13.99 | 15669648 |
MESH:D013927 |
Thrombosis |
|
Warfarin |
13.99 | 17672075 19300499 17245631 15720958 11518727 11307788 |
MESH:D013953 |
Thymus Neoplasms |
|
Benzene |
4.63 | 10850423 |
MESH:D013959 |
Thyroid Diseases |
|
Amiodarone |
10.95 | 19731979 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
10.95 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
10.69 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
10.69 | 17909728 16010429 |
MESH:D013964 |
Thyroid Neoplasms |
|
Propylthiouracil |
10.69 | 15710170 |
MESH:D013971 |
Thyrotoxicosis |
|
Amiodarone |
4.54 | 19584973 18020914 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
4.88 | 19048282 |
MESH:D016171 |
Torsades de Pointes |
|
Amiodarone |
3.87 | 17467628 11989578 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
14.39 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
14.39 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
14.39 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
14.39 | 17572228 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
14.39 | 16712894 17572228 8653321 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
3.99 | 10091137 |
MESH:D014594 |
Uterine Neoplasms |
|
Benzene |
8.54 | 12562636 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
8.54 | 14692618 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.65 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.26 | 12125929 |
MESH:D014657 |
Vasculitis |
|
Warfarin |
5.55 | 20337814 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
13.22 | 16837676 |
MESH:D054556 |
Venous Thromboembolism |
|
Warfarin |
13.22 | 18776969 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
22.94 | 15869587 14671159 |
MESH:D020246 |
Venous Thrombosis |
|
ethinyl estradiol-desogestrel combination |
22.94 | 15869587 |
MESH:D020246 |
Venous Thrombosis |
|
Levonorgestrel |
22.94 | 15869587 |
MESH:D020246 |
Venous Thrombosis |
|
Warfarin |
22.94 | 15733061 14723717 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
3.90 | 17334414 17638931 16364871 17678736 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.22 | 16343187 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.92 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.11 | 17120751 |